Group One Trading
AGIO icon

Group One Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Group One Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.64M Sell
151,994
-21,285
-12% -$646K 0.01% 1348
2026
Q1 		$5.86M Buy
173,279
+6,665
+4% +$189K 0.01% 1175
2025
Q4 		$4.54M Buy
+166,614
New +$5.85M 0.01% 1589
2025
Q2 		– Sell
-13,188
Closed -$400K – 7871
2025
Q1 		$386K Sell
13,188
-5,232
-28% -$174K ﹤0.01% 3352
2024
Q4 		$605K Buy
+18,420
New +$865K ﹤0.01% 3017
2024
Q3 		– Sell
-10,103
Closed -$459K – 6564
2024
Q2 		$436K Buy
+10,103
New +$365K ﹤0.01% 2697
2024
Q1 		– Sell
-1,035
Closed -$27.7K – 6945
2023
Q4 		$23K Sell
1,035
-20,300
-95% -$455K ﹤0.01% 5632
2023
Q3 		$528K Buy
21,335
+8,357
+64% +$221K ﹤0.01% 2850
2023
Q2 		$368K Buy
12,978
+7,467
+135% +$186K ﹤0.01% 3340
2023
Q1 		$127K Buy
5,511
+2,474
+81% +$65.7K ﹤0.01% 4085
2022
Q4 		$85.3K Buy
3,037
+1,148
+61% +$32.4K ﹤0.01% 4569
2022
Q3 		$53K Sell
1,889
-38,031
-95% -$1.02M ﹤0.01% 5355
2022
Q2 		$885K Sell
39,920
-32,626
-45% -$737K ﹤0.01% 2871
2022
Q1 		$2.11M Buy
+72,546
New +$2.22M ﹤0.01% 2350
2021
Q4 		– Sell
-4,914
Closed -$198K – 8120
2021
Q3 		$227K Buy
+4,914
New +$237K ﹤0.01% 5036
2021
Q1 		– Sell
-10,661
Closed -$528K – 7523
2020
Q4 		$462K Buy
10,661
+8,034
+306% +$318K ﹤0.01% 3330
2020
Q3 		$92K Buy
+2,627
New +$115K ﹤0.01% 4243
2020
Q2 		– Sell
-35,677
Closed -$1.65M – 5736
2020
Q1 		$1.27M Buy
+35,677
New +$1.65M 0.01% 1347
2019
Q4 		– Sell
-5,828
Closed -$220K – 5059
2019
Q3 		$189K Buy
5,828
+5,628
+2,814% +$233K ﹤0.01% 3123
2019
Q2 		$10K Sell
200
-964
-83% -$51.5K ﹤0.01% 4406
2019
Q1 		$79K Sell
1,164
-3,812
-77% -$222K ﹤0.01% 3327
2018
Q4 		$229K Buy
+4,976
New +$307K ﹤0.01% 2578
2018
Q2 		– Sell
-2,951
Closed -$257K – 5042
2018
Q1 		$241K Sell
2,951
-25,271
-90% -$1.95M ﹤0.01% 2635
2017
Q4 		$1.61M Buy
28,222
+5,167
+22% +$325K 0.01% 1331
2017
Q3 		$1.54M Buy
23,055
+1,168
+5% +$70.2K 0.01% 1236
2017
Q2 		$1.13M Buy
21,887
+10,079
+85% +$515K 0.01% 1356
2017
Q1 		$690K Sell
11,808
-9,654
-45% -$463K 0.01% 1618
2016
Q4 		$896K Buy
21,462
+11,152
+108% +$585K 0.01% 1379
2016
Q3 		$545K Sell
10,310
-3,297
-24% -$144K 0.01% 1753
2016
Q2 		$570K Buy
13,607
+782
+6% +$38.6K 0.01% 1640
2016
Q1 		$521K Buy
12,825
+10,108
+372% +$432K 0.01% 1658
2015
Q4 		$176K Buy
2,717
+2,261
+496% +$148K ﹤0.01% 2586
2015
Q3 		$32K Buy
+456
New +$44.6K ﹤0.01% 3798
2015
Q2 		– Sell
-2,695
Closed -$290K – 4814
2015
Q1 		$254K Buy
2,695
+143
+6% +$16K ﹤0.01% 2187
2014
Q4 		$286K Buy
+2,552
New +$228K ﹤0.01% 2004

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Group One Trading's AGIO Position: Q2 2026 in Review

Group One Trading reduced its Agios Pharmaceuticals (AGIO) stake by 12% in Q2 2026, selling an estimated $646K and leaving 151,994 shares worth $5.64M. The position accounts for 0.01% of the portfolio, ranked #1348.

Group One Trading first reported a position in AGIO in Q4 2014 and has held it in 35 quarters since. The position peaked at $5.86M in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Group One Trading held 151,994 shares of Agios Pharmaceuticals worth $5.64M as of Q2 2026.
  • Group One Trading sold 21,285 Agios Pharmaceuticals shares in Q2 2026, an estimated $646K.
  • Agios Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q2 2026, its #1348 holding.
  • Group One Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 35 quarters since.
  • Group One Trading's Agios Pharmaceuticals position peaked at $5.86M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.